Lièvre L, Meyohas MC, Costagliola D. Impact of opportunistic diseases on survival in HIV-infected patients in France, 1992-1997. Clinical Epidemiology Group from Centres d’Information et de Soins de l’Immunodéficience Humaine. AIDS. 10 sept 1999;13(13):1789‑90. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/10509587
Mary-Krause M, Billaud E. Impact of Kaposi’s sarcoma in occurrence of opportunistic central nervous system disease. Clinical Epidemiology Group. AIDS. 1 oct 1999;13(14):1985‑7. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/10513664
Phillips AN, Grabar S, Tassie JM, Costagliola D, Lundgren JD, Egger M. Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups. AIDS. 22 oct 1999;13(15):2075‑82. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/10546860
Tassie JM, Gasnault J, Bentata M, Deloumeaux J, Boué F, Billaud E, et al. Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV. AIDS. 1 oct 1999;13(14):1881‑7. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/10513646
